The Montalcino Aortic Consortium seeks to improve clinical outcomes of individuals with
heritable thoracic aortic disease through this large international collaboration of medical
professionals. The goal of this meeting is to define gene-based treatment guidelines from
MAC achievements so far and prioritize research questions, using the infrastructure of
MAC, to be addressed by the consortium over the next few years.